Literature DB >> 30815464

Changes of Early Sepsis Biomarker Presepsin Level during Hemodialysis: Influence of β2-Microglobulin Clearance of Dialysis Membrane: A Preliminary Study.

Jun Shiota1.   

Abstract

BACKGROUND: Although presepsin (P-SEP) is an early sepsis biomarker, sepsis is often suspected after starting hemodialysis (HD). To enhance the utility of P-SEP, we investigated whether pre-HD P-SEP levels could be predicted using the P-SEP levels from blood samples collected after starting HD.
METHODS: We observed P-SEP level changes due to HD and dialyzer passage in HD patients using a dialysis membrane with a β2-microglobulin (β2-MG) clearance of either ≥50 mL/min (high-flux) or < 30 mL/min (intermediate-flux). We calculated the removal ratios for the elimination of P-SEP or the predicted pre-HD P-SEP levels based on the correction of hemoconcentration.
RESULTS: The P-SEP levels significantly decreased at 4 h after starting HD (n = 8) using membranes with a β2-MG clearance ≥50 mL/min; the removal ratios at 2 and 4 h were 42.8 ± 7.9% and 58.8 ± 18.4%, respectively. In contrast, the P-SEP levels did not decrease during the passage of dialyzer in 2 patients with a β2-MG clearance < 30 mL/min, and the P-SEP levels increased during HD in all patients (n = 10, including the abovementioned 2 patients) with a β2-MG clearance < 30 mL/min. The predicted pre-HD P-SEP levels (y) were strongly correlated with the actually measured pre-HD P-SEP levels (x) (R 2 = 0.9562) using the regression equation: y = 1.0987x.
CONCLUSION: The levels of P-SEP with a molecular weight near that of β2-MG decreased similarly to those of β2-MG during HD using membranes with a β2-MG clearance ≥50 mL/min. On the contrary, the levels of P-SEP rather increased during HD with a β2-MG clearance < 30 mL/min, suggesting that P-SEP appeared not to be eliminated. Furthermore, the pre-HD P-SEP levels might be predictable by the correction of hemoconcentration using even blood samples collected after starting HD with a β2-MG clearance < 30 mL/min.

Entities:  

Keywords:  Biomarker; CD14; Dialysis membrane; Hemodialysis; Presepsin

Year:  2018        PMID: 30815464      PMCID: PMC6388441          DOI: 10.1159/000493505

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  15 in total

Review 1.  Hemodialysis membranes: interleukins, biocompatibility, and middle molecules.

Authors:  Walter H Hörl
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Development of a point-of-care assay system for measurement of presepsin (sCD14-ST).

Authors:  Yoshikazu Okamura; Hiroyuki Yokoi
Journal:  Clin Chim Acta       Date:  2011-08-03       Impact factor: 3.786

3.  Procalcitonin for accurate detection of infection in haemodialysis.

Authors:  S Herget-Rosenthal; G Marggraf; F Pietruck; J Hüsing; M Strupat; T Philipp; A Kribben
Journal:  Nephrol Dial Transplant       Date:  2001-05       Impact factor: 5.992

4.  Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.

Authors:  Rosemary Ouseph; Colin A Hutchison; Richard A Ward
Journal:  Nephrol Dial Transplant       Date:  2007-12-21       Impact factor: 5.992

5.  Mass transfer mechanisms in high-performance membrane dialyzers.

Authors:  Akihiro C Yamashita
Journal:  Contrib Nephrol       Date:  2011-08-08       Impact factor: 1.580

6.  Japanese society for dialysis therapy clinical guideline for "Maintenance hemodialysis: hemodialysis prescriptions".

Authors:  Yuzo Watanabe; Hideki Kawanishi; Kazuyuki Suzuki; Shigeru Nakai; Kenji Tsuchida; Kaoru Tabei; Takashi Akiba; Ikuto Masakane; Yoshiaki Takemoto; Tadashi Tomo; Noritomo Itami; Yasuhiro Komatsu; Motoshi Hattori; Michio Mineshima; Akihiro Yamashita; Akira Saito; Hidemune Naito; Hideki Hirakata; Jun Minakuchi
Journal:  Ther Apher Dial       Date:  2015-03       Impact factor: 1.762

7.  Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis.

Authors:  Tatjana Vodnik; Goran Kaljevic; Tanja Tadic; Nada Majkic-Singh
Journal:  Clin Chem Lab Med       Date:  2013-10       Impact factor: 3.694

8.  Phagocytosis by human monocytes is required for the secretion of presepsin.

Authors:  Yasuyuki Arai; Kiyomi Mizugishi; Kazuhiko Nonomura; Katsuki Naitoh; Akifumi Takaori-Kondo; Kouhei Yamashita
Journal:  J Infect Chemother       Date:  2015-05-06       Impact factor: 2.211

9.  Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production.

Authors:  Sudhanshu Agrawal; Pavan Gollapudi; Reza Elahimehr; Madeline V Pahl; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2009-11-09       Impact factor: 5.992

10.  Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury.

Authors:  Yoshihiko Nakamura; Hiroyasu Ishikura; Takeshi Nishida; Yasumasa Kawano; Rie Yuge; Reiko Ichiki; Akira Murai
Journal:  BMC Anesthesiol       Date:  2014-10-04       Impact factor: 2.217

View more
  2 in total

1.  Prediction of Postoperative Sepsis Based on Changes in Presepsin Levels of Critically Ill Patients with Acute Kidney Injury after Abdominal Surgery.

Authors:  Chang Hwan Kim; Eun Young Kim
Journal:  Diagnostics (Basel)       Date:  2021-12-09

2.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.